Cart
sales@molnova.com
c-FMS-IN-8
CAS No. 885704-21-2
c-FMS-IN-8( —— )
Catalog No. M16411 CAS No. 885704-21-2
c-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 112 | In Stock |
|
| 5MG | 107 | In Stock |
|
| 10MG | 164 | In Stock |
|
| 25MG | 278 | In Stock |
|
| 50MG | 369 | In Stock |
|
| 100MG | 540 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namec-FMS-IN-8
-
NoteResearch use only, not for human use.
-
Brief Descriptionc-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.
-
Descriptionc-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
RecptorCSF1R
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number885704-21-2
-
Formula Weight406.5239
-
Molecular FormulaC23H30N6O
-
Purity>98% (HPLC)
-
SolubilityDMSO
-
SMILESCC1CCN(CC1)C2=C(C=CC(=C2)N3CCN(CC3)C)NC(=O)C4=CC(=CN4)C#N
-
Chemical Name1H-Pyrrole-2-carboxamide, 4-cyano-N-[4-(4-methyl-1-piperazinyl)-2-(4-methyl-1-piperidinyl)phenyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Illig CR, et al. Bioorg Med Chem Lett. 2008 Mar 1;18(5):1642-8.
2. Meegalla SK, et al. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3632-7.
molnova catalog
related products
-
PLX-5622
PLX-5622 is a highly selective brain penetrant and oral active CSF1R inhibitor.
-
Edicotinib
Edicotinib (JNJ 40346527, PRV 6527) is a potent, selective, orally bioavailable CSF-1R inhibitor with IC50 of 3.2 nM; shows weak affinity for KIT and FLT3 (IC50= 20 nM and 190 nM, respectively).
-
Gimsilumab
Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
